Sep 2020 $4 M No. 10 $2 to $10 million 10
Clinipace Inc: Raise no. 10, Sep 2020 × Investors in this round 10 investors had bought by the notice of Oct 6, 2020: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $10 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Monteleone · Executive Officer, Director David Fitzgerald · Director Jeremy Mario · Director Jesse Watson · Director Melissa Daniels · Director Steve Skolsky · Director Steven List · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.”Signed by Miranda R. Miller, Attorney-in-fact. Source: SEC Form D, newest notice filed Oct 6, 2020. Read the notice at the SEC .
debt, options SEC Oct 2019 $15 M No. 9 $10 to $50 million 16
Clinipace Inc: Raise no. 9, Oct 2019 × Investors in this round 16 investors had bought by the notice of Feb 3, 2020: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Monteleone · Executive Officer, Director Chris Semple · Director David Fitzgerald · Director Jeremy Mario · Director Jesse Watson · Director Melissa Daniels · Director Steve Skolsky · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.”Signed by Miranda R. Miller, Attorney-in-fact. Source: SEC Form D and 1 amendment, newest notice filed Feb 3, 2020. Read the notice at the SEC .
debt, options SEC Jul 2019 $4 M No. 8 $2 to $10 million 13
Clinipace Inc: Raise no. 8, Jul 2019 × Investors in this round 13 investors had bought by the notice of Aug 7, 2019: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Monteleone · Executive Officer, Director Chris Semple · Director David Fitzgerald · Director Jeremy Mario · Director Jesse Watson · Director Melissa Daniels · Director Steve Skolsky · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Aug 7, 2019. Read the notice at the SEC .
equity SEC Mar 2019 $4 M No. 7 $2 to $10 million 13
Clinipace Inc: Raise no. 7, Mar 2019 × Investors in this round 13 investors had bought by the notice of Mar 14, 2019: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Monteleone · Executive Officer, Director Chris Semple · Director David Fitzgerald · Director Jeremy Mario · Director Jesse Watson · Director Melissa Daniels · Director Steve Skolsky · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Mar 14, 2019. Read the notice at the SEC .
equity SEC Aug 2018 $6 M No. 6 $2 to $10 million 13
Clinipace Inc: Raise no. 6, Aug 2018 × Investors in this round 13 investors had bought by the notice of Sep 10, 2018: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Monteleone · Executive Officer, Director Chris Semple · Director David Fitzgerald · Director Jeremy Mario · Director Jesse Watson · Director Melissa Daniels · Director Steve Skolsky · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Sep 10, 2018. Read the notice at the SEC .
equity SEC Dec 2017 $10 M No. 5 $10 to $50 million 16
Clinipace Inc: Raise no. 5, Dec 2017 × Investors in this round 16 investors had bought by the notice of Dec 19, 2017: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $20 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Monteleone · Executive Officer, Director Chris Semple · Director David Fitzgerald · Director Jeremy Mario · Director Jesse Watson · Director Melissa Daniels · Director Steve Skolsky · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Dec 19, 2017. Read the notice at the SEC .
equity SEC Jul 2016 $4 M No. 4 $2 to $10 million 10
Clinipace Inc: Raise no. 4, Jul 2016 × Investors in this round 10 investors had bought by the notice of Jul 21, 2016: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher K. Porter · Executive Officer Jeff L. Williams · Executive Officer, Director Mark K. Ubert · Executive Officer Brian K. Carney · Director David K. Fitzgerald · Director Gena K. Reed · Director Jeremy K. Mario · Director Jesse K. Watson · Director Ken K. Lee · Director Melissa K. Daniels · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Chris Porter, Secretary. Source: SEC Form D, newest notice filed Jul 21, 2016. Read the notice at the SEC .
equity SEC Jan 2015 $18 M Issued in a merger or acquisition $10 to $50 million 13
Clinipace Inc: Private sale, Jan 2015 × Investors in this round 13 investors had bought by the notice of Jan 15, 2015: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $32 M offered; $15 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher K. Porter · Executive Officer Jeff L. Williams · Executive Officer, Director Mark K. Ubert · Executive Officer Brian K. Carney · Director David K. Fitzgerald · Director Gena K. Reed · Director Jeremy K. Mario · Director Jesse K. Watson · Director Ken K. Lee · Director Melissa K. Daniels · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Ubert, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 15, 2015. Read the notice at the SEC .
equity SEC Jan 2014 $3 M No. 3 $2 to $10 million 1
Clinipace Inc: Raise no. 3, Jan 2014 × Investors in this round 1 investor had bought by the notice of Feb 7, 2014: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher K. Porter · Executive Officer Jeff L. Williams · Executive Officer, Director Mark K. Ubert · Executive Officer Brian K. Carney · Director David K. Fitzgerald · Director Gena K. Reed · Director Jeremy K. Mario · Director John K. Crumpler · Director Julia K. Gregory · Director Ken K. Lee · Director Melissa K. Daniels · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher K. Porter, President & Secretary. Source: SEC Form D, newest notice filed Feb 7, 2014. Read the notice at the SEC .
debt, options SEC Oct 2012 $9 M No. 2 $2 to $10 million 3
Clinipace Inc: Raise no. 2, Oct 2012 × Investors in this round 3 investors had bought by the notice of Oct 25, 2012: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher K. Porter · Executive Officer Jeff L. Williams · Executive Officer, Director Brian K. Carney · Director Gena K. Reed · Director Jeremy K. Mario · Director John K. Crumpler · Director Julia K. Gregory · Director Ken K. Lee · Director Melissa K. Daniels · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Byron B. Kirkland, Attorney-in-Fact. Source: SEC Form D, newest notice filed Oct 25, 2012. Read the notice at the SEC .
equity, debt, options SEC Sep 2012 $13 M Issued in a merger or acquisition $10 to $50 million 6
Clinipace Inc: Private sale, Sep 2012 × Investors in this round 6 investors had bought by the notice of Sep 17, 2012: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $13 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher K. Porter · Executive Officer Jeff L. Williams · Executive Officer, Director Gena K. Reed · Director Jeremy K. Mario · Director John K. Crumpler · Director Julia K. Gregory · Director Ken K. Lee · Director Melissa K. Daniels · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Byron B. Kirkland, Attorney-in-Fact. Source: SEC Form D, newest notice filed Sep 17, 2012. Read the notice at the SEC .
debt, options SEC Sep 2011 $16 M No. 1 $10 to $50 million 14
Clinipace Inc: Raise no. 1, Sep 2011 × Investors in this round 14 investors had bought by the notice of Oct 4, 2011: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $16 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher K. Porter · Executive Officer Jeff L. Williams · Executive Officer, Director Jeremy K. Mario · Director John K. Crumpler · Director Ken K. Lee · Director Melissa K. Daniels · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher K. Porter, Secretary. Source: SEC Form D, newest notice filed Oct 4, 2011. Read the notice at the SEC .
equity SEC